SCHEMBL10172227

SCHEMBL10172227

COc1ccc(/C(C#N)=N/O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ GFER P55789 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.47
▸ NQO2 P16083 1/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ PMP22 Q01453 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6706162 1.00 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL6706161 1.00 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL12994619 0.85 NPSR1 (0.47) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL10233427 0.85 NPSR1 (0.47) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL23504933 0.83 NPSR1 (0.50) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL1344768 0.83 NPSR1 (0.50) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL12454187 0.83 NPSR1 (0.46) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL1344772 0.83 NPSR1 (0.50) SMN1; SMN2ALDH1A1NPSR1MAPK1HSP90AA1
SCHEMBL10859395 0.81 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPSR1MAPK1KDM4E
SCHEMBL10859399 0.81 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPSR1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287179-A1 HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL CORPORATION (JP) 2023-09-14 — — US disclosed
US-11579528-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2023-02-14 — — US disclosed
US-11561471-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-01-24 — — US disclosed
US-11543749-B2 Resist composition and method for producing resist pattern, and method for producing plated molded article SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-01-03 — — US disclosed
US-11194252-B2 Cured film-forming composition NISSAN CHEMICAL CORPORATION (JP) 2021-12-07 — — US disclosed
US-20210278765-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN, AND METHOD FOR PRODUCING PLATED MOLDED ARTICLE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-09-09 — — US disclosed
EP-3745207-B1 PATTERN-FORMING METHOD USING ELECTRON BEAMS FOR EUV RAYS AND USE OF THIS METHOD FOR FORMING A FINE CIRCUIT OF A SEMICONDUCTOR DEVICE FUJIFILM CORP (JP) 2021-06-16 — — EP disclosed
US-10969685-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-04-06 — — US disclosed
WO-2021014956-A1 PHOTOSENSITIVE RESIN COMPOSITION 日産化学株式会社 2021-01-28 — — WO disclosed
US-10890847-B2 Pattern forming method, resist pattern, method for manufacturing electronic device, and electronic device FUJIFILM CORPORATION (JP) 2021-01-12 — — US disclosed
US-20070042290-A1 resin containing acrylic ester monomers capable of increasing solubility in alkali developer by action of acid, acid generator, aryldicycloalkylsulfonium compounds, and nonionic surfactant; semiconductors, integrated circuits FUJI PHOTO FILM CO., LTD. 2007-02-22 — — US disclosed
US-20070042290-A1 resin containing acrylic ester monomers capable of increasing solubility in alkali developer by action of acid, acid generator, aryldicycloalkylsulfonium compounds, and nonionic surfactant; semiconductors, integrated circuits FUJI PHOTO FILM CO., LTD. 2007-02-22 — — US disclosed
US-7179579-B2 Radiation-sensitive composition FUJI PHOTO FILM CO., LTD. (JP) 2007-02-20 — — US disclosed
US-20070031757-A1 Positive photosensitive composition and method of pattern formation with the same FUJI PHOTO FILM CO., LTD. 2007-02-08 — — US disclosed
US-20070031757-A1 Positive photosensitive composition and method of pattern formation with the same FUJI PHOTO FILM CO., LTD. 2007-02-08 — — US disclosed
US-20070026343-A1 Chemical amplification-type resist composition and production process thereof FUJI PHOTO FILM CO., LTD. 2007-02-01 — — US disclosed
US-20070026343-A1 Chemical amplification-type resist composition and production process thereof FUJI PHOTO FILM CO., LTD. 2007-02-01 — — US disclosed
US-20070020559-A1 Positive-type photosensitive resin composition and cured film manufactured therefrom NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 — — US disclosed
US-20070020559-A1 Positive-type photosensitive resin composition and cured film manufactured therefrom NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 — — US disclosed
US-20070003871-A1 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. 2007-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287179-A1 HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME TTPA, USP1, USP2 SMN1; SMN2 3817/4885ALDH1A1 874/4885NPSR1 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback